Home/Filings/4/0000899243-22-038387
4//SEC Filing

Cardama Alfonso Quintas 4

Accession 0000899243-22-038387

CIK 0001750019other

Filed

Dec 12, 7:00 PM ET

Accepted

Dec 13, 8:26 PM ET

Size

8.6 KB

Accession

0000899243-22-038387

Insider Transaction Report

Form 4
Period: 2022-12-09
Cardama Alfonso Quintas
Chief Medical Officer
Transactions
  • Sale

    Common Stock

    2022-12-09$1.13/sh4,461$5,041118,797 total
  • Sale

    Common Stock

    2022-12-12$1.10/sh4,586$5,040114,211 total
  • Sale

    Common Stock

    2022-12-13$1.06/sh4,752$5,042109,459 total
Holdings
  • Common Stock

    123,258
Footnotes (1)
  • [F1]The sales reported represent the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. These sales were automatic and intended to qualify under Rule 10b5-1.

Issuer

TCR2 THERAPEUTICS INC.

CIK 0001750019

Entity typeother

Related Parties

1
  • filerCIK 0001760104

Filing Metadata

Form type
4
Filed
Dec 12, 7:00 PM ET
Accepted
Dec 13, 8:26 PM ET
Size
8.6 KB